The company will offer 9.1 million shares for between $10 and $12 each. At an $11 sale price, HealthEquity would have a fully diluted market value of $625 million, according to a NASDAQ report.
HealthEquity has an 8 percent share of the health savings account custodial market, making it one of five largest market players, according to the report.
More Articles on the Health IT Market:
3 Health IT Accelerators With New Classes of Startups
GE Healthcare Sees Slight Profit Increase in Q2
Castlight Health, Teladoc Partner for New Employer Offerings
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
